USage of chitosan for Femoral (USF) haemostasis after percutaneous procedures: a comparative open label study.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  EuroIntervention

• Publication date

  2011-04-01

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.4244/EIJV6I9A192PMID 21518684
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A prospective, randomized trial of topical hemostasis patch use following percutaneous coronary and peripheral intervention.

  2008cited by this paper
• Periprocedural Stroke and Cardiac Catheterization

  2008cited by this paper
• Hemostatic properties of glucosamine-based materials.

  2007cited by this paper
• Chitosan Dressing Provides Hemostasis in Swine Femoral Arterial Injury Model

  2007cited by this paper
• Variation in the definitions of bleeding in clinical trials of patients with acute coronary syndromes and undergoing percutaneous coronary interventions and its impact on the apparent safety of antithrombotic drugs.

  2007cited by this paper
• A propensity analysis of the risk of vascular complications after cardiac catheterization procedures with the use of vascular closure devices.

  2007cited by this paper
• Refined characterization of the association between kidney function and mortality in patients undergoing cardiac catheterization.

  2006cited by this paper
• Propensity score analysis of vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention 1998–2003

  2006cited by this paper
• Making sense of the preclinical literature on advanced hemostatic products.

  2006cited by this paper
• Effectiveness of manual pressure hemostasis following transfemoral coronary angiography in patients on therapeutic warfarin anticoagulation.

  2006cited by this paper
• Treatment of dialysis access puncture wound bleeding with chitosan dressings

  2006cited by this paper
• Comparison of hemorrhage control agents applied to lethal extremity arterial hemorrhages in swine.

  2005cited by this paper
• *N-Terminal Pro-BNP Levels in Patients with Congestive Heart Failure and Implantable Cardioverter-Defibrillator or Biventricular Pacemaker-Defibrillator Therapies.

  2005cited by this paper
• Hemorrhage control in the battlefield: role of new hemostatic agents.

  2005cited by this paper
• Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis.

  2004cited by this paper
• Development of Hemostatic Dressings for Use in Military Operations

  2004cited by this paper
• Sex differences in outcomes after cardiac catheterization: effect modification by treatment strategy and time.

  2004cited by this paper
• Effect of a chitosan-based hemostatic dressing on blood loss and survival in a model of severe venous hemorrhage and hepatic injury in swine.

  2003cited by this paper
• Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study.

  2003cited by this paper
• Chitosan enhances platelet adhesion and aggregation.

  2003cited by this paper
• Clinical evaluation of SyvekPatch in patients undergoing interventional, EPS and diagnostic cardiac catheterization procedures.

  2002cited by this paper
• Management of Infected Femoral Closure Devices

  2002cited by this paper
• Infection is an Unusual But Serious Complication of a Femoral Artery Catheterization Site Closure Device

  2001cited by this paper
• The 6Fr Angio-Seal arterial closure device: results from a multimember prospective registry.

  2001cited by this paper
• Suture-mediated closure of the femoral access site after cardiac catheterization: results of the suture to ambulate aNd discharge (STAND I and STAND II) trials.

  2000cited by this paper
• 3 Complications of Cardiac Catheterization

  2000cited by this paper
• A novel vascular sealing device for closure of percutaneous arterial access sites.

  1999cited by this paper
• Final report of the European multi-center registry using the Deutt™ vascular sealing device

  1999cited by this paper
• A randomized trial of vascular hemostasis techniques to reduce femoral vascular complications after coronary intervention.

  1998cited by this paper
• Efficacy and safety of a hemostatic puncture closure device with early ambulation after coronary angiography. Angio-Seal Investigators.

  1998cited by this paper
• Efficacy and Safety of a Hemostatic Puncture Closure Device With Early Ambulation After Coronary Angiography fn1

  1998cited by this paper
• Multivariable model for prediction of risk of significant complication during diagnostic cardiac catheterization. The Registry Committee of the Society for Cardiac Angiography & Interventions.

  1993cited by this paper
• Cardiac catheterization 1990: a report of the Registry of the Society for Cardiac Angiography and Interventions (SCA&I).

  1991cited by this paper
• Coronary arteriography 1984-1987: a report of the Registry of the Society for Cardiac Angiography and Interventions. I. Results and complications.

  1989cited by this paper
• Current complications of diagnostic and therapeutic cardiac catheterization.

  1988cited by this paper
• Percutaneous Transluminal Coronary Angioplasty: Report of Complications from the National Heart, Lung, and Blood Institute PTCA Registry

  1983cited by this paper
• Complications associated with cardiac catheterization and angiography.

  1982cited by this paper
• Complications of cardiac catheterization.

  1968cited by this paper

• AI-enabled, QbD-aligned Predictive, and Sustainable Design of Natural Polymer-based Drug Delivery Systems

  2026cites this paper
• Chitosan‐Based Hydrogels as Antibacterial/Antioxidant/Anti‐Inflammation Multifunctional Dressings for Chronic Wound Healing

  2024cites this paper
• An architecturally rational hemostat for rapid stopping of massive bleeding on anticoagulation therapy

  2024influential citation
• Zeolite Dressing Bag in Trauma for Hemorrhage Control: Case of 90 Patients Used

  2022cites this paper
• Stem cell and tissue engineering approaches in pressure ulcer treatment

  2021cites this paper
• The Efficacy of Chitosan Hemostatic Pad on Hemostatic Function in Patients Undergoing Cardiac Catheterization: A Systematic Review and Meta-Analysis.

  2021cites this paper
• Erste Hilfe

  2021cites this paper
• European Resuscitation Council Guidelines 2021: First aid.

  2021cites this paper
• Recent Advances in Chitosan-Based Metal Nanocomposites for Wound Healing Applications

  2020cites this paper
• Control of Severe, Life-Threatening External Bleeding in the Out-of-Hospital Setting: A Systematic Review

  2020cites this paper
• Executive Summary 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations

  2020cites this paper
• 2020 International Consensus on First Aid Science With Treatment Recommendations.

  2020cites this paper
• Executive Summary 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations Circulation

  2020cites this paper
• 2020 American Heart Association and American Red Cross Focused Update for First Aid.

  2020cites this paper
• 2020 International Consensus on First Aid Science With Treatment Recommendations.

  2020cites this paper
• Adult Advanced Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations

  2020cites this paper
• The hemostatic efficacy of chitosan-pads in hemodialysis patients with significant bleeding tendency

  2017cites this paper
• Hemostasis pad combined with compression device after transradial coronary procedures: A randomized controlled trial

  2017cites this paper
• Comparison of manual compression and vascular hemostasis devices after coronary angiography or percutaneous coronary intervention through femoral artery access: A meta-analysis of randomized controlled trials.

  2017cites this paper
• Recent advances in engineered chitosan-based nanogels for biomedical applications.

  2017cites this paper
• Hemostyptic property of chitosan: Opportunities and pitfalls

  2016cites this paper
• Chitosan hemostatic dressing for control of hemorrhage from femoral arterial puncture site in dogs

  2015cites this paper
• Chitosan Hemostatic Dressing

  2015cites this paper
• An open multicenter comparative randomized clinical study on chitosan

  2015cites this paper
• A Comparison of 2 Devices for Radial Artery Hemostasis After Transradial Coronary Intervention

  2015cites this paper
• Effect of Recombinant Human Epidermal Growth Factor Impregnated Chitosan Film on Hemostasis and Healing of Blood Vessels

  2014cites this paper
• Chitosan-based Dressing for the Treatment of External/Accessible Bleedings in Children With Bleeding Tendency

  2014cites this paper
• A New Hemostasis Tool after Percutaneous Angioplasty: The Hemcontm Pad Hemostasis Device

  2014cites this paper
• Chitosans for delivery of nucleic acids

  2013cites this paper